Proto Labs, Inc. $PRLB Shares Purchased by XXEC Inc.

Key Points

• XXEC Inc. increased its Proto Labs position by 2,060.4% in the second quarter, acquiring 1.2 million additional shares for a total of 1.26 million shares. Proto Labs now represents 55.7% of XXEC’s portfolio, while institutional investors collectively own 84.54% of the stock.
• Proto Labs reported quarterly EPS of $0.60, exceeding the $0.53 analyst consensus, while revenue of $149.34 million also topped expectations and rose 10.5% year over year.
• Analyst sentiment remains favorable, with the stock carrying an average “Buy” rating and an average price target of $89.00. Shares recently opened at $79.48, compared with a 52-week range of $45.10 to $93.00.

XXEC Inc. raised its position in shares of Proto Labs, Inc. (NYSE:PRLB - Free Report) by 2,060.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,261,547 shares of the industrial products company's stock after acquiring an additional 1,203,154 shares during the period. Proto Labs makes up 55.7% of XXEC Inc.'s portfolio, making the stock its biggest holding. XXEC Inc. owned approximately 5.27% of Proto Labs worth $111,461,682,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Group One Trading LLC acquired a new position in shares of Proto Labs during the 4th quarter worth about $25,000. NewEdge Advisors LLC boosted its stake in Proto Labs by 7,380.0% during the 1st quarter. NewEdge Advisors LLC now owns 748 shares of the industrial products company's stock valued at $26,000 after purchasing an additional 738 shares during the period. NBC Securities Inc. acquired a new stake in Proto Labs in the 4th quarter valued at approximately $46,000. USA Financial Formulas bought a new position in Proto Labs in the 1st quarter worth approximately $52,000. Finally, Modus Advisors LLC bought a new position in Proto Labs in the 4th quarter worth approximately $57,000. 84.54% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Sven Wehrwein sold 2,000 shares of the stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $77.28, for a total value of $154,560.00. Following the completion of the transaction, the director owned 32,505 shares of the company's stock, valued at $2,511,986.40. This represents a 5.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.30% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. Weiss Ratings lowered Proto Labs from a "buy (b)" rating to a "buy (b-)" rating in a report on Tuesday. Benchmark boosted their target price on shares of Proto Labs from $70.00 to $91.00 and gave the stock a "buy" rating in a research report on Thursday, July 2nd. Wall Street Zen lowered shares of Proto Labs from a "strong-buy" rating to a "buy" rating in a research report on Saturday, July 18th. Needham & Company LLC upgraded shares of Proto Labs from a "hold" rating to a "buy" rating and set a $87.00 target price for the company in a research note on Monday, August 3rd. Finally, Zacks Research raised shares of Proto Labs from a "hold" rating to a "strong-buy" rating in a report on Thursday, August 6th. One research analyst has rated the stock with a Strong Buy rating and three have given a Buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Buy" and an average price target of $89.00.

Proto Labs Price Performance

PRLB opened at $79.48 on Friday. The company has a market capitalization of $1.90 billion, a P/E ratio of 63.58 and a beta of 1.40. The firm's fifty day moving average price is $80.56 and its two-hundred day moving average price is $70.19. Proto Labs, Inc. has a fifty-two week low of $45.10 and a fifty-two week high of $93.00.

Proto Labs (NYSE:PRLB - Get Free Report) last announced its quarterly earnings data on Friday, July 31st. The industrial products company reported $0.60 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.53 by $0.07. The company had revenue of $149.34 million during the quarter, compared to analysts' expectations of $144.53 million. Proto Labs had a net margin of 5.44% and a return on equity of 4.80%. The business's revenue was up 10.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.41 EPS. Proto Labs has set its Q3 2026 guidance at 0.560-0.640 EPS. On average, equities research analysts expect that Proto Labs, Inc. will post 1.46 EPS for the current fiscal year.

Proto Labs Company Profile

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.

Want to see what other hedge funds are holding PRLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Proto Labs, Inc. (NYSE:PRLB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source